BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 20191092)

  • 1. Cannabinoids as novel anti-inflammatory drugs.
    Nagarkatti P; Pandey R; Rieder SA; Hegde VL; Nagarkatti M
    Future Med Chem; 2009 Oct; 1(7):1333-49. PubMed ID: 20191092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.
    Hegde VL; Hegde S; Cravatt BF; Hofseth LJ; Nagarkatti M; Nagarkatti PS
    Mol Pharmacol; 2008 Jul; 74(1):20-33. PubMed ID: 18388242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation.
    Do Y; McKallip RJ; Nagarkatti M; Nagarkatti PS
    J Immunol; 2004 Aug; 173(4):2373-82. PubMed ID: 15294950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of cannabinoid-based drugs.
    Klein TW; Newton CA
    Adv Exp Med Biol; 2007; 601():395-413. PubMed ID: 17713029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
    Rieder SA; Chauhan A; Singh U; Nagarkatti M; Nagarkatti P
    Immunobiology; 2010 Aug; 215(8):598-605. PubMed ID: 19457575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cannabinoid system and cytokine network.
    Klein TW; Lane B; Newton CA; Friedman H
    Proc Soc Exp Biol Med; 2000 Oct; 225(1):1-8. PubMed ID: 10998193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases.
    Rodríguez Mesa XM; Moreno Vergara AF; Contreras Bolaños LA; Guevara Moriones N; Mejía Piñeros AL; Santander González SP
    Cannabis Cannabinoid Res; 2021 Jun; 6(3):196-210. PubMed ID: 34030476
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of CB
    Joffre J; Yeh CC; Wong E; Thete M; Xu F; Zlatanova I; Lloyd E; Kobzik L; Legrand M; Hellman J
    J Immunol; 2020 Jun; 204(12):3339-3350. PubMed ID: 32385136
    [No Abstract]   [Full Text] [Related]  

  • 10. Cannabinoid receptors in atherosclerosis.
    Steffens S; Mach F
    Curr Opin Lipidol; 2006 Oct; 17(5):519-26. PubMed ID: 16960500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cannabis and cannabinoids as drugs].
    Khiabani HZ; Mørland J
    Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of cannabinoid agents in animals.
    Chaperon F; Thiébot MH
    Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.
    Greineisen WE; Turner H
    Int Immunopharmacol; 2010 May; 10(5):547-55. PubMed ID: 20219697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological actions of cannabinoids.
    Pertwee RG
    Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Cannabinoids on T-cell Function and Resistance to Infection.
    Eisenstein TK; Meissler JJ
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):204-16. PubMed ID: 25876735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on the immune system.
    Cabral GA; Staab A
    Handb Exp Pharmacol; 2005; (168):385-423. PubMed ID: 16596782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids.
    Grotenhermen F
    Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):507-30. PubMed ID: 16266285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.